News – Page 72 – Endpoints News

Novo Nordisk budgets $409M for new quality control lab in Denmark

6 months ago

Moderna CEO defends pandemic prep efforts with critics set to enter Trump’s administration

6 months ago

Trade group tells FDA that semaglutide is not too 'complex' for compounding

6 months ago

Bluebird and Vertex's sickle cell gene therapies to kick off new Medicaid access model

6 months ago

Novavax sells Czech facility to Novo Nordisk for $200M to cut costs

6 months ago

AstraZeneca's new EVP of international amid China investigation; Janux’s $300M offering

6 months ago

Relmada's rapid-acting NMDA depression drug expected to fail second Phase 3

6 months ago

As 23andMe struggles, another genetic testing company bets on drug discovery

6 months ago

Updated: CEO of UnitedHealth insurance unit shot and killed in New York in what police call ‘a brazen, targeted ...

6 months ago

GSK partners with Rgenta on RNA-targeted small molecules for oncology, other areas

6 months ago

Ro’s weight loss business more than doubled in the last year. Now it’s trying to prove its program works

6 months ago

Dewpoint partners its ALS program, eyes JPM to raise a Series D

6 months ago

Atea blueprints Phase 3 for hepatitis C combo after mid-stage win

6 months ago

Lilly beats Novo in bellwether head-to-head weight loss study

6 months ago

GSK makes another ADC deal, this time with BioNTech's partner DualityBio

6 months ago

On heels of MariTide data, Danish obesity biotech discloses €80M Series A

6 months ago

Lilly drops body mass ranges from FDA label for weight loss drug

6 months ago

GSK terminates Phase 2 trial of HBV therapeutic vaccine

6 months ago

SEC and Kiromic settle over biotech's failure to disclose clinical trial holds ahead of stock offering

6 months ago

Eli Lilly, Pfizer stress independence of telehealth partners in response to senators

6 months ago

Applied Therapeutics gets FDA warning letter over study of rejected rare disease drug

6 months ago

Coherus makes final, $483M pivot away from biosimilars

6 months ago

Ipsen secures rights to preclinical T cell engager in $610M pact with French biotech

6 months ago

Relay licenses cancer drug to Korean biotech for $75M

6 months ago

First page Previous page 69 70 717273 74 75 Next page Last page